[Pharmacopuncture in combined treatment of children with neurosensory hypoacusis].

Sukhareva MP, Aref'eva NA, Farkhutdinova LV

Vestnik otorinolaringologii1 Jan 2000Cited by 2 (Europe PMC)

PMID11187070PepBankPUB-11187070

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study6

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone6

In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Cerebrolysin.

01HumanNot a test of Cerebrolysin aloneNon-randomized trialEfficacy outcome
In children with neurosensory hypoacusis, combined pharmacopuncture with cerebrolysin lowered tonal thresholds by more than 15 dB in 36%.
In plain wordsIn children with hearing loss, the combined cerebrolysin regimen lowered hearing thresholds in 36%.
Peptide
Cerebrolysin
Outcome
DecreaseTonal thresholds
Study
n = 120
Outcome group
Sensory perception · Nervous system and cognition
Measurements
Threshold reduction
> 15 dB
36% of children
Responders
36%
combined pharmacopuncture
Source sentences
Summary
The treatment lowered tonal thresholds more than by 15 dB in 36% children.
3 context sentences(design, population, supporting numbers)
Summary · context
Pharmacopuncture treatment (cerebrolysin, cavinton, prozerin) was given to 120 children with neurosensory hypoacusis aged 4-15 years.
Summary · context
The treatment consisted of 3 courses 10 days each with 7-10-day interval.
Summary · context
The drugs were injected in the dose 0.1 ml in biologically active points according to the original technique.
In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.
Report a problemFND-1118707001
02HumanNot a test of Cerebrolysin aloneNon-randomized trialEfficacy outcome
In children with neurosensory hypoacusis, combined pharmacopuncture with cerebrolysin increased speech intelligibility.
In plain wordsIn children with hearing loss, speech intelligibility increased after the combined cerebrolysin regimen.
Peptide
Cerebrolysin
Outcome
IncreaseSpeech intelligibility
Study
n = 120
Outcome group
Sensory perception · Nervous system and cognition
Source sentences
Summary
Speech intelligibility increased, head ache and nose in the ears relieved in 85% cases.
3 context sentences(design, population, supporting numbers)
Summary · context
Pharmacopuncture treatment (cerebrolysin, cavinton, prozerin) was given to 120 children with neurosensory hypoacusis aged 4-15 years.
Summary · context
The treatment consisted of 3 courses 10 days each with 7-10-day interval.
Summary · context
The drugs were injected in the dose 0.1 ml in biologically active points according to the original technique.
In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.
Report a problemFND-1118707002
03HumanNot a test of Cerebrolysin aloneNon-randomized trialEfficacy outcome
In children with neurosensory hypoacusis, combined pharmacopuncture with cerebrolysin relieved headache, with the grouped response reported in 85% of cases.
In plain wordsIn children with hearing loss, the combined cerebrolysin regimen relieved headache. The grouped response occurred in 85%.
Peptide
Cerebrolysin
Outcome
DecreaseHeadache
Study
n = 120
Outcome group
Pain · Nervous system and cognition
Source sentences
Summary
Speech intelligibility increased, head ache and nose in the ears relieved in 85% cases.
3 context sentences(design, population, supporting numbers)
Summary · context
Pharmacopuncture treatment (cerebrolysin, cavinton, prozerin) was given to 120 children with neurosensory hypoacusis aged 4-15 years.
Summary · context
The treatment consisted of 3 courses 10 days each with 7-10-day interval.
Summary · context
The drugs were injected in the dose 0.1 ml in biologically active points according to the original technique.
In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.
Report a problemFND-1118707003
04HumanNot a test of Cerebrolysin aloneNon-randomized trialEfficacy outcome
In children with neurosensory hypoacusis, combined pharmacopuncture with cerebrolysin relieved ear noise, with the grouped response reported in 85% of cases.
In plain wordsIn children with hearing loss, the combined cerebrolysin regimen relieved ear noise. The grouped response occurred in 85%.
Peptide
Cerebrolysin
Outcome
DecreaseEar noise
Study
n = 120
Outcome group
Sensory perception · Nervous system and cognition
Source sentences
Summary
Speech intelligibility increased, head ache and nose in the ears relieved in 85% cases.
3 context sentences(design, population, supporting numbers)
Summary · context
Pharmacopuncture treatment (cerebrolysin, cavinton, prozerin) was given to 120 children with neurosensory hypoacusis aged 4-15 years.
Summary · context
The treatment consisted of 3 courses 10 days each with 7-10-day interval.
Summary · context
The drugs were injected in the dose 0.1 ml in biologically active points according to the original technique.
In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.
Report a problemFND-1118707004
05HumanNot a test of Cerebrolysin aloneNon-randomized trialEfficacy outcome
In children with neurosensory hypoacusis, adaptation to hearing aids was positive after combined pharmacopuncture with cerebrolysin.
In plain wordsIn children with hearing loss, hearing aid adaptation was positive after the combined cerebrolysin regimen.
Peptide
Cerebrolysin
Outcome
IncreaseHearing aid adaptation
Study
n = 120
Outcome group
Sensory perception · Nervous system and cognition
Source sentences
Summary
Adaptation to the hearing aid was positive.
3 context sentences(design, population, supporting numbers)
Summary · context
Pharmacopuncture treatment (cerebrolysin, cavinton, prozerin) was given to 120 children with neurosensory hypoacusis aged 4-15 years.
Summary · context
The treatment consisted of 3 courses 10 days each with 7-10-day interval.
Summary · context
The drugs were injected in the dose 0.1 ml in biologically active points according to the original technique.
In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.
Report a problemFND-1118707005
06HumanNot a test of Cerebrolysin aloneNon-randomized trialEfficacy outcome
In children with neurosensory hypoacusis, REG indicated normalization of hemodynamics after combined pharmacopuncture with cerebrolysin.
In plain wordsIn children with hearing loss, blood flow measurements indicated normalization after the combined cerebrolysin regimen.
Peptide
Cerebrolysin
Outcome
Not applicableHemodynamics on REG
Study
n = 120
Outcome group
Vascular function · Cardiovascular
Source sentences
Summary
Clinical evidence was confirmed by REG picture indicating normalization of hemodynamics.
3 context sentences(design, population, supporting numbers)
Summary · context
Pharmacopuncture treatment (cerebrolysin, cavinton, prozerin) was given to 120 children with neurosensory hypoacusis aged 4-15 years.
Summary · context
The treatment consisted of 3 courses 10 days each with 7-10-day interval.
Summary · context
The drugs were injected in the dose 0.1 ml in biologically active points according to the original technique.
In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.
Report a problemFND-1118707006

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

Version 2Current
14 Oct 2026, 05:02 UTC
Study results updated
Version 1
14 Oct 2026, 01:46 UTC
First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.